99 related articles for article (PubMed ID: 2545336)
21. Functional analysis of the 5'-flanking region of the human gastrin-releasing peptide gene in small cell lung carcinoma cell lines.
Nagalla SR; Spindel ER
Cancer Res; 1994 Aug; 54(16):4461-7. PubMed ID: 8044796
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of the human delta opioid receptor in lung cancer.
Schreiber G; Campa MJ; Prabhakar S; O'Briant K; Bepler G; Patz EF
Anticancer Res; 1998; 18(3A):1787-92. PubMed ID: 9673405
[TBL] [Abstract][Full Text] [Related]
23. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
[TBL] [Abstract][Full Text] [Related]
24. Expression of the c-myb oncogene in human small cell lung carcinoma.
Griffin CA; Baylin SB
Cancer Res; 1985 Jan; 45(1):272-5. PubMed ID: 2578097
[TBL] [Abstract][Full Text] [Related]
25. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
26. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
27. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
Jakowlew SB; Mathias A; Chung P; Moody TW
Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
29. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma.
Joseph B; Ekedahl J; Sirzen F; Lewensohn R; Zhivotovsky B
Biochem Biophys Res Commun; 1999 Aug; 262(2):381-7. PubMed ID: 10462484
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
[TBL] [Abstract][Full Text] [Related]
31. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Salgia R; Li JL; Ewaniuk DS; Wang YB; Sattler M; Chen WC; Richards W; Pisick E; Shapiro GI; Rollins BJ; Chen LB; Griffin JD; Sugarbaker DJ
Oncogene; 1999 Jan; 18(1):67-77. PubMed ID: 9926921
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Zhu YM; Webster SJ; Flower D; Woll PJ
Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
[TBL] [Abstract][Full Text] [Related]
33. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
[TBL] [Abstract][Full Text] [Related]
34. The clinical role of MDR1 gene expression in human lung cancer.
Oka M; Fukuda M; Sakamoto A; Takatani H; Fukuda M; Soda H; Kohno S
Anticancer Res; 1997; 17(1B):721-4. PubMed ID: 9066608
[TBL] [Abstract][Full Text] [Related]
35. Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes.
Falcioni R; Cimino L; Gentileschi MP; D'Agnano I; Zupi G; Kennel SJ; Sacchi A
Exp Cell Res; 1994 Jan; 210(1):113-22. PubMed ID: 7505746
[TBL] [Abstract][Full Text] [Related]
36. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
[TBL] [Abstract][Full Text] [Related]
37. Quantitative description of classic and variant small cell lung cancer cell lines by nuclear image cytometry.
Broers JL; Pahlplatz MM; Katzko MW; Oud PS; Ramaekers FC; Carney DN; Vooijs GP
Cytometry; 1988 Sep; 9(5):426-31. PubMed ID: 2846247
[TBL] [Abstract][Full Text] [Related]
38. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Vieau D; Linard CG; Mbikay M; Lenne F; Chretien M; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1992 Jun; 36(6):597-603. PubMed ID: 1424185
[TBL] [Abstract][Full Text] [Related]
39. 7B2, a possible marker for nonfunctioning pancreatic islet cell tumor.
Iguchi H; Yasuda D; Yamada Y; Funakoshi A; Wakasugi H; Bloom SR; Chretien M
Horm Metab Res; 1991 Oct; 23(10):486-9. PubMed ID: 1662184
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.
Broers JL; Ramaekers FC; Rot MK; Oostendorp T; Huysmans A; van Muijen GN; Wagenaar SS; Vooijs GP
Cancer Res; 1988 Jun; 48(11):3221-9. PubMed ID: 2452687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]